Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
- PMID: 22120009
- PMCID: PMC5108406
- DOI: 10.1038/ng.993
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
Abstract
To identify risk variants for multiple myeloma, we conducted a genome-wide association study of 1,675 individuals with multiple myeloma and 5,903 control subjects. We identified risk loci for multiple myeloma at 3p22.1 (rs1052501 in ULK4; odds ratio (OR) = 1.32; P = 7.47 × 10(-9)) and 7p15.3 (rs4487645, OR = 1.38; P = 3.33 × 10(-15)). In addition, we observed a promising association at 2p23.3 (rs6746082, OR = 1.29; P = 1.22 × 10(-7)). Our study identifies new genomic regions associated with multiple myeloma risk that may lead to new etiological insights.
Conflict of interest statement
Statement The authors declare no competing financial interests.
Figures
References
-
- Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351:1860–73. - PubMed
-
- Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046–60. - PubMed
-
- Kyle RA, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med. 2002;346:564–9. - PubMed
-
- Altieri A, Chen B, Bermejo JL, Castro F, Hemminki K. Familial risks and temporal incidence trends of multiple myeloma. Eur J Cancer. 2006;42:1661–70. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
